Health
STAT+: Pharmalittle: We’re reading about an approval for novel drug for strokes, a warning for GLP-1 drugs, and more
TL;DR
- The FDA approved a novel drug to reduce recurrence of stroke, the agency is warning that GLP-1s carry a potential risk for an eye condition, and more pharma news of
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 10, 2026 · Updated 11/10/2026, 2:30:32 PM · Reported with: STAT
Sources (1)
NRI Bytes writes its own articles from the reporting below.
STAT — STAT+: Pharmalittle: We’re reading about an approval for novel drug for strokes, a warning for GLP-1 drugs, and moreUp next · Health
Texas family gets $21.6 million after faulty plumbing makes home unfit to live in
Read next →
More stories
Health
The best turkey roasting pans for every budget and bird size
47m ago
Health
19+ cozy gifts that could turn anyone into a homebody this holiday season
1h ago
Health
Selena Gomez says vaping has changed her voice. Can e-cigarettes really affect your vocal cords – and is it reversible?
1h ago
Health
STAT+: Wyden, Sanders hand-in-hand on ‘Medicare for All’ initiative
2h ago
